| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,118 |
21,909 |
$1.19M |
| 90832 |
Psychotherapy, 30 minutes with patient |
6,333 |
3,365 |
$269K |
| T2023 |
Targeted case management; per month |
282 |
223 |
$75K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,436 |
2,911 |
$69K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
983 |
916 |
$54K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,381 |
1,177 |
$39K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
322 |
320 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,152 |
625 |
$20K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
442 |
397 |
$16K |
| 90791 |
Psychiatric diagnostic evaluation |
168 |
158 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
558 |
496 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
597 |
555 |
$9K |
| 90756 |
|
377 |
365 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
104 |
101 |
$6K |
| 84703 |
|
725 |
682 |
$5K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
498 |
346 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
387 |
371 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
804 |
769 |
$4K |
| 80305 |
|
338 |
196 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,038 |
862 |
$3K |
| 81025 |
|
430 |
413 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
59 |
59 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
141 |
124 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
595 |
486 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
937 |
887 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
449 |
382 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
168 |
151 |
$593.55 |
| 90674 |
|
14 |
14 |
$235.63 |
| Q3014 |
Telehealth originating site facility fee |
189 |
175 |
$90.82 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
14 |
12 |
$72.17 |
| 99499 |
|
77 |
62 |
$0.01 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
37 |
16 |
$0.00 |